Theoretical aspects of P-glycoprotein mediated drug efflux on the distribution volume of anaesthetic-related drugs in the brain

Anaesthesia and Intensive Care

Volumn 30, Issue 2, 2002, Pages 183-191

  Upton, R N ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Brain: Cerebral distribution volume; Pharmacokinetics: P glycoprotein

Indexed keywords

ANESTHETIC AGENT; FENTANYL; GLYCOPROTEIN P; MORPHINE;

ANALYTIC METHOD; ARTICLE; BLOOD BRAIN BARRIER; CELL MEMBRANE PERMEABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG BRAIN LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; INTRACELLULAR MEMBRANE; LIPOPHILICITY; MOLECULAR WEIGHT; THEORETICAL MODEL; THEORETICAL STUDY; VALIDATION PROCESS;

EID: 0036109575     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0203000210     Document Type: Article

References (23)

1. The physiological function of drug-transporting P-glycoproteins
2. Function, evolution and structure of multidrug resistance protein (MRP)
3. Effect of GF120918, a potent P-glycoprotein inhibitor, on morphine pharmacokinetics and pharmacodynamics in the rat
4. Interaction with P-glycoprotein and transport of erythromycin, midazolam and ketoconazole in Caco-2 cells
5. Active transport of fentanyl by the blood-brain barrier
6. Opiate-induced analgesia is increased and prolonged in mice lacking P-glycoprotein
7. Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat
8. The role of P-glycoprotein in blood-brain barrier transport of morphine: Transcortical microdialysis studies in mdr1a (-/-) and mdr1a (+/+) mice
9. A physiologic approach to hepatic drug clearance
10. Effect of altered plasma protein binding on apparent volume of distribution
11. A model of the kinetics and dynamics of the induction of anaesthesia in sheep. Parameter estimation for thiopentone and comparison with propofol
12. The pharmacokinetic optimisation of opioid treatment in acute pain therapy
13. Structure and quantification of a physiological model of the distribution of injected agents and inhaled anaesthetics
14. Measurement of cerebral capillary perfusion with a fluorescent label
15. A physiological model for the distribution of injected agents, with special reference to pethidine
16. Animal models for studying transport across the blood-brain barrier
17. The cerebral pharmacokinetics of meperidine and alfentanil in conscious sheep
18. Poor permeability of morphine 3-glucuronide and morphine 6-glucuronide through the blood-brain barrier in the rat
19. Evidence for P-glycoprotein-modulated penetration of morphine-6-glucuronide into brain capillary endothelium
20. Tissue distribution of fentanyl and alfentanil in the rat cannot be described by a blood flow limited model
21. Active transport of fentanyl by the blood-brain barrier
22. Kinetics of the multidrug transporter (P-glycoprotein) and its reversal
23. Quantitative structure-pharmacokinetics relationships: I. Development of a whole-body physiologically based model to characterize changes in pharmacokinetics across a homologous series of barbiturates in the rat